“Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s109. doi:10.25251/skin.7.supp.109.